FDA Clearance Tracker · K163336
xTAG Cystic Fibrosis 60 Kit v2, xTAG Data Analysis Software (TDAS) CFTR
Last checked: Nov 20, 2026Latest source record: Dec 15, 2016 (this decision)Source: openFDAMethods & limitations
Decided
Dec 15, 2016
Unknown
Time to decision
17 days
Received Nov 28, 2016. Calendar days, including time FDA spent waiting on the applicant.
Pathway
510(k)
Special
Device class
Class II
The decision
- FDA number
- K163336
- Device name
- xTAG Cystic Fibrosis 60 Kit v2, xTAG Data Analysis Software (TDAS) CFTR
- Applicant
- Luminex Molecular Diagnostics, Inc.
- Applicant location
- Toronto, CA
- Received
- Nov 28, 2016
- Decided
- Dec 15, 2016
- Decision
- Unknown
- Submission type
- Special
Device type
- Device type
- System, Cystic Fibrosis Transmembrane Conductance Regulator, Gene Mutation Detection (NUA)
- Device class
- Class II
- Regulation
- 21 CFR 866.5900
- Specialty
- Laboratory Medicine & Pathology
How new is this?
These are facts about FDA's records. They are not a judgment about the device.
- It is not the first decision under product code NUA. The earliest in FDA's data is DEN050004, decided May 9, 2005.
- It is not on FDA's public list of Breakthrough Devices with marketing authorization (list dated June 30, 2026). FDA does not publish which devices hold the designation before they are authorized, and the list is updated only a few times a year.
Source documents
- FDA database record for K163336
- The applicant filed a statement instead of a public summary, or the summary is not at FDA's usual address. Check the FDA record.
The predicate devices this clearance relied on are named in the summary document. We do not extract them yet.
Other decisions for Luminex Molecular Diagnostics, Inc.
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
K242613 · Decided Oct 2, 2024 · 29 days after receipt
Device type: Respiratory Virus Panel Nucleic Acid Assay System (OCC) · Laboratory Medicine & Pathology
7 more FDA decisions with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.